For patients with rheumatoid arthritis (RA), analyzing immune cell diversity in peripheral blood revealed five major immunotype groups, each exhibiting a different response to various biologic or targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs). This is according to a 2024 study published in Annals of the Rheumatic Disease that aimed to stratify the patients based on…
Fellows and masters, members at different stages in their careers, are both important to rheumatology. During the year I co-chaired the Membership and Awards Committee with ARP President Adam Goode , PT, DPT, PhD, I gained an even greater appreciation of the essential roles that fellows and masters both play in shaping our specialty, as…
Disease detection, access to care and remote patient monitoring are just a few areas in which AI is expected to aid rheumatology, but there will still be room for the human touch.
In her latest volunteer role with the ACR, Natasha Ruth, MD, MS, shares her plans for the Division Directors Committee and how she’s equipped to achieve these goals.
State rheumatology society meetings and other conferences provide continuing medical education, networking and collaboration opportunities. Check this year’s calendar for rheumatology events near you.
New clinical features, opinion pieces and much more—outgoing Arthritis & Rheumatology Editor-in-Chief Daniel H. Solomon, MD, MPH, discusses how the journal has evolved and where it’s going.
ACR Open Rheumatology Editor-in-Chief Andras Perl, MD, PhD, discusses his unique career and his approach to balancing basic and translational research articles with outcome-focused articles within the journal.
Compassion, clear communication, empathy and more—Samantha C. Shapiro, MD, provides practical advice on how to connect with your patients during appointments.
Rheumatologists must do some detective work into a patient’s signs and symptoms when considering a psoriatic arthritis diagnosis, according to Philip J. Mease, MD, MACR
Research from Baker et al. demonstrated a strong association between the presence of metabolic syndrome and lower response rates to advanced therapies in patients with RA.